NDAOPHTHALMICSOLUTION/DROPS
Approved
Mar 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VISINE L.R. is an ophthalmic decongestant containing oxymetazoline hydrochloride, a selective alpha-adrenergic agonist used to relieve redness, itching, and irritation of the eyes due to minor irritations, allergies, or fatigue. The drug works by constricting blood vessels in the conjunctiva, reducing hyperemia and associated ocular symptoms. It is available as a solution/drops formulation for direct ocular administration.
LOE Approaching
With LOE approaching and moderate competitive pressure (30%), the brand team is likely operating in maintenance or strategic portfolio defense mode with reduced headcount and investment focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
Started Apr 2019
1,105 enrolled
Rosacea
Career Relevance
Working on VISINE L.R. as LOE approaches offers limited growth trajectory but provides stable, foundational commercial experience in OTC portfolio management and brand defense. Professionals should view this role as a springboard to higher-growth products or as preparation for line extension, international, or adjacent therapeutic area opportunities.
Brand Manager
Worked on VISINE L.R. at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.